FDA to review growth hormone safety, follows EU (Reuters, 22 December 2010)

22 Dec 2010


The US Food and Drug Administration has announced that it will follow the European Medicines Agency in conducting a safety review of growth hormone replacement therapy, after a study showed that high doses may increase mortality.

Full article


Share this story